Dr Hannah R Nieto BSc MBBS FRCS (ORL-HNS) PhD

Hannah Nieto

Department of Metabolism and Systems Science
Clinician Scientist

Contact details

Address
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Qualifications

  • PhD in Molecular Biology, Univeristy of Birmingham, 2020
  • FRCS, Royal College of Surgeons England, 2021
  • MBBS, Imperial College London, 2009
  • BSc (Hons) in Medical Sciences with Surgery and Anaesthesia, Imperial College London, 2007

Biography

Hannah Nieto has recently been appointed as a Clinician Scientist on a BHP Fellowship at the University of Birmingham. Hannah is a Head and Neck and Thyroid surgeon, trained in Otorhinolaryngology (ENT surgery) in the West Midlands, and is currently undertaking a clinical Advanced H&N fellowship at the Manchester Royal Infirmary. Academically Hannah is working in the field of thyroid molecular genomics, with an interest in thyroid cancer and bioinformatics. Hannah delivers modules on statistics and bioinformatics at UoB for intercalated students and supervises iMSc Anatomy students, coaching them through performing systematic reviews and metanalyses. Her PhD was completed in the molecular biology of thyroid cancer recurrence, encompassing programming and wet lab discovery science. Hannah sits on the national ENT NIHR CRN. Her research focus now is genetics in diagnostics and prognostics in thyroid cancer.

Teaching

  • Bioinformatics and Statistics for iMSc intercalating medical students 
  • Thyroid and HPA small group teaching sessions, University of Birmingham 2015 – current
  • ENT West Midlands FRCS course
  • ENT West Midlands emergency course
  • ITM fellowship teaching – clincal medical students on clinical examinations
  • Anatomy demonstrator under Professor Peter Abrahams 2010 – 2011

Postgraduate supervision

Hannah is currently supervising clinical/discovery science PhDs, please get in contact if you would like to discuss this further.

Other activities

  • ENT National NIHR CRN 2021 - current
  • British Thyroid Association Executive committee, 2019 - 2023
  • Student & Foundation Doctors in Otolaryngology (SFO) committee,  2020 - present
  • Post-CCT Training Interface Groups Fellowship national representative

Publications

Recent publications

Article

Manivannan, S, Kocbiyik, M, Banga, D, Nieto, H, Thomas, S, Read, M, McCabe, C & Smith, V 2024, 'Proto-oncogene regulation of thyroid cancer cell motility through altered focal adhesions', Thyroid, vol. 34, no. S1, Poster 0208, pp. A52-A52. https://doi.org/10.1089/thy.2024.89756.rc.abstracts

Read, M, Brookes, K, Zha, L, Manivannan, S, Kim, J, Kocbiyik, M, Fletcher, A, Gorvin, CM, Firth, G, Fruhwirth, G, Nicola, J, Jhiang, S, Ringel, M, Campbell, M, Sunassee, K, Blower, P, Boelaert, K, Nieto, H, Smith, V & McCabe, C 2023, 'Combined Vorinostat and Chloroquine Inhibit Sodium Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo', Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-23-2043

Abstract

Manivannan, S, Kocbiyik, M, Banga, D, Afzal, A, Zha, L, Brookes, K, Nieto, HR, Thomas, S, Read, ML, McCabe, CJ & Smith, VE 2024, 'Proto-oncogene PBF regulation of cell adhesion and motility', Thyroid Research, vol. 17, no. S1, PO3. https://doi.org/10.1186/s13044-024-00203-w

Read, M, Brookes, K, Zha, L, Kim, J, Fear, J, Wongsanit, S, Small, B, Nieto, H, Kannappan, V, Wang, W, Jhiang, S, Ringel, M, Campbell, M, Sunassee, K, Blower, P, Boelaert, K, Smith, V & McCabe, C 2024, 'Transcriptional Reprogramming Using a New Dual NIS Agonist Enhances Radioiodide Uptake and Facilitates Greater Predictive Utility for Thyroid Cancer Recurrence', Thyroid, vol. 34, no. S1, Poster 0201, pp. A49-A50. https://doi.org/10.1089/thy.2024.89756.rc.abstracts

Brookes, K, Zha, L, Kim, J, Wongsanit, S, Fear, J, Small, B, Nieto, HR, Kannappan, V, Wang, W, Jhiang, S, Ringel, MD, Campbell, MJ, Sunassee, K, Blower, PJ, Boelaert, K, Smith, VE, Read, ML & McCabe, CJ 2024, 'Transcriptional reprogramming using a new dual NIS agonist enhances radioiodide uptake with implications for predicting thyroid cancer recurrence', Thyroid Research, vol. 17, no. S1, OR2. https://doi.org/10.1186/s13044-024-00203-w

Brookes, K, Zha, L, Small, B, Kim, J, Manivannan, S, Thornton, C, Kannappan, V, Wang, W, Nieto, H, Sunassee, K, Blower, P, Smith, V, Read, M & McCabe, C 2023, 'A copper-based metabolite of disulfiram upregulates sodium iodide symporter (NIS) gene expression to enhance thyroidal uptake of radionuclides in vivo', Endocrine Abstracts, vol. 94, OC7.1. https://doi.org/10.1530/endoabs.94.OC7.1

Manivannan, S, Banga, D, Kocbiyik, M, Read, M, Zha, L, Brookes, K, Nieto, H, McCabe, C & Smith, V 2023, 'A critical role for the proto-oncogene PBF in regulating cellular adhesion and motility in thyroid cancer', Endocrine Abstracts, vol. 94, OC2.6. https://doi.org/10.1530/endoabs.94.OC2.6

Brookes, K, Zha, L, Kim, J, Small, B, Kocbiyik, M, Manivannan, S, Kannappan, V, Wang, W, Sunassee, K, Blower, P, Nieto, H, Smith, V, Read, M & McCabe, C 2023, 'Copper-based therapeutics increase sodium/iodide symporter (NIS) transcription and enhance radioiodide uptake in thyroid cancer cells', Endocrine Abstracts, vol. 90, OC11.1. https://doi.org/10.1530/endoabs.90.OC11.1

Manivannan, S, Kocbiyik, M, Alshahrani, M, EI-Asrag, M, Zha, L, Brookes, K, Nieto, H, Read, M, Beggs, A, McCabe, C & Smith, V 2023, 'Elucidating the mechanisms via which the proto-oncogene Pbf stimulates cell motility in thyroid tumor progression', Thyroid, vol. 33, no. S1, Poster 338, pp. A62-A62. https://doi.org/10.1089/thy.2023.29156.abstracts

Manivannan, S, Kocbiyik, M, Alshahrani, M, El-Asrag, ME, Zha, L, Brookes, K, Nieto, H, Read, M, Beggs, A, McCabe, C & Smith, V 2023, 'Elucidating the mechanisms via which the proto-oncogene PBF stimulates cell motility in thyroid tumour progression', Thyroid Research, vol. 16, no. S1, PO2, pp. 6-6. https://doi.org/10.1186/s13044-023-00170-8

Brookes, K, Zha, L, Kim, J, Kocbiyik, M, Manivannan, S, Sunassee, K, Blower, P, Nieto, H, Smith, V, Read, M & McCabe, C 2023, 'Exploiting endocytic factors as druggable targets to enhance sodium iodide symporter activity with clinical implications for radioiodide therapy', Thyroid Research, vol. 16, no. Supplement 1, OR4, pp. 4-4. https://doi.org/10.1186/s13044-023-00170-8

Brookes, K, Zha, L, Kim, J, Kocbiyik, M, Manivannan, S, Sunassee, K, Blower, P, Nieto, H, Smith, V, Read, M & McCabe, C 2023, 'Exploiting endocytic factors as druggable targets to enhance sodium iodide symporter activity with clinical implications for radioiodide therapy', Thyroid, vol. 33, no. S1, Poster 273, pp. A33-A34. https://doi.org/10.1089/thy.2023.29156.abstracts

Preprint

Brookes, K, Thornton, CEM, Zha, L, Kim, J, Small, B, Fear, JS, Nieto, HR, Western, H, Jones, A, Pham, TT, Bottegoni, G, Cox, LR, Kannappan, V, Wang, W, Gorvin, CM, Stover, DG, Spitzweg, C, Jhiang, S, Ringel, MD, Campbell, MJ, Sunassee, K, Blower, PJ, Boelaert, K, Smith, VE, Read, ML & McCabe, CJ 2024 'Clinical Implications of Dually Targeting the Sodium Iodide Symporter in Canonical and Non-Canonical Settings' SSRN. <https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4996070>

Read, M, Brookes, K, Zha, L, Manivannan, S, Kim, J, Kocbiyik, M, Fletcher, A, Gorvin, CM, Firth, G, Fruhwirth, G, Nicola, J, Jhiang, S, Ringel, M, Campbell, M, Sunassee, K, Blower, P, Boelaert, K, Nieto, H, Smith, V & McCabe, C 2023 'Dissecting endocytic mechanisms reveals new molecular targets to enhance sodium iodide symporter activity with clinical relevance to radioiodide therapy' bioRxiv. https://doi.org/10.1101/2023.05.22.541733

Review article

Jamshaid, W, Jamshaid, M, Coulson, C, Sharma, N, Muzaffar, J & Nieto, H 2023, 'A systematic review on the efficacy of tranexamic acid in head and neck surgery', Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, vol. 48, no. 4, pp. 527-539. https://doi.org/10.1111/coa.14059

View all publications in research portal